Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis
Open Access
- 9 May 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 25540
Abstract
The development of precision medicine, together with the multiplication of targeted therapies and associated molecular biomarkers, call for major progress in genetic analysis methods, allowing increased multiplexing and the implementation of more complex decision trees, without cost increase or loss of robustness. We present a platform combining droplet microfluidics and magnetic tweezers, performing RNA purification, reverse transcription and amplification in a fully automated and programmable way, in droplets of 250nL directly sampled from a microtiter-plate. This platform decreases sample consumption about 100 fold as compared to current robotized platforms and it reduces human manipulations and contamination risk. The platform’s performance was first evaluated on cell lines, showing robust operation on RNA quantities corresponding to less than one cell and then clinically validated with a cohort of 21 breast cancer samples, for the determination of their HER2 expression status, in a blind comparison with an established routine clinical analysis.Keywords
This publication has 38 references indexed in Scilit:
- Ultrahigh-Throughput Mammalian Single-Cell Reverse-Transcriptase Polymerase Chain Reaction in Microfluidic DropsAnalytical Chemistry, 2013
- SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesBMC Cancer, 2013
- Programmable Magnetic Tweezers and Droplet Microfluidic Device for High‐Throughput Nanoliter Multi‐Step AssaysAngewandte Chemie International Edition, 2012
- Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity CriteriaJNCI: Journal of the National Cancer Institute, 2011
- Analysis of gene expression at the single-cell level using microdroplet-based microfluidic technologyBiomicrofluidics, 2011
- Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approachesBritish Journal of Cancer, 2011
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Microfluidic high-throughput encapsulation and hydrodynamic self-sorting of single cellsProceedings of the National Academy of Sciences, 2008
- Reactions in Droplets in Microfluidic ChannelsAngewandte Chemie International Edition, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001